0000950123-16-016121.txt : 20160502 0000950123-16-016121.hdr.sgml : 20160502 20160502115114 ACCESSION NUMBER: 0000950123-16-016121 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20160331 FILED AS OF DATE: 20160502 DATE AS OF CHANGE: 20160502 EFFECTIVENESS DATE: 20160502 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Omega Fund Management, LLC CENTRAL INDEX KEY: 0001637359 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-16844 FILM NUMBER: 161610580 BUSINESS ADDRESS: STREET 1: 185 DARTMOUTH STREET, SUITE 502 CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 617 502 6538 MAIL ADDRESS: STREET 1: 185 DARTMOUTH STREET, SUITE 502 CITY: BOSTON STATE: MA ZIP: 02116 FORMER COMPANY: FORMER CONFORMED NAME: Omega Fund Management (US) Inc. DATE OF NAME CHANGE: 20150320 13F-HR 1 primary_doc.xml 13F-HR LIVE false true false 0001637359 XXXXXXXX 03-31-2016 03-31-2016 Omega Fund Management, LLC
185 Dartmouth Street, Suite 502 Boston MA 02116
13F HOLDINGS REPORT 028-16844 N
Anne-Mari Paster Chief Financial Officer, Omega Fund Management, LLC 617.502.6538 /s/ Anne-Mari Paster Boston MA 04-28-2016 0 11 144173 false
INFORMATION TABLE 2 form13fInfoTable.xml INFORMATION TABLE FOR FORM 13F CymaBay Therapeutics Common Stock 23257D103 818 606100 SH SOLE 606100 0 0 Dicerna Pharmaceuticals Common Stock 253031108 1198 223457 SH SOLE 223457 0 0 Editas Medicine Common Stock 28106W103 3627 105007 SH SOLE 105007 0 0 Egalet Common Stock 28226B104 19310 2814928 SH SOLE 2814928 0 0 ESSA Pharma Common Stock 29668H104 5515 1696969 SH SOLE 1696969 0 0 FibroGen Common Stock 31572Q808 17504 822175 SH SOLE 822175 0 0 Juno Therapeutics Common Stock 48205A109 46832 1229512 SH SOLE 1229512 0 0 Nabriva Therapeutics Sponsored ADR 62957M104 10267 1145890 SH SOLE 1145890 0 0 Paratek Pharmaceuticals Common Stock 699374302 32447 2138872 SH SOLE 2138872 0 0 Pieris Pharmaceuticals Common Stock 720795103 4720 2483949 SH SOLE 2483949 0 0 Proteon Therapeutics Common Stock 74371L109 1935 250000 SH SOLE 250000 0 0